No Data
No Data
Canopy Growth, Capricor Therapeutics, GT Biopharma Among Healthcare Movers
Capricor Therapeutics to Present at Upcoming Investor Conferences
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare
This Just In: Analysts Are Boosting Their Capricor Therapeutics, Inc. (NASDAQ:CAPR) Outlook for This Year
Shareholders in Capricor Therapeutics, Inc. (NASDAQ:CAPR) may be thrilled to learn that the analysts have just delivered a major upgrade to their near-term forecasts. The analysts greatly increased
Catalyst Announces US Launch of Duchenne MD Drug Agamree
Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year?
Capricor Therapeutics, Inc. Is Worried About This – Should You Be Worried Too?
No Data